Print Page  Close Window

SEC Filings

S-1
VITAE PHARMACEUTICALS, INC filed this Form S-1 on 08/12/2014
Entire Document
 

Table of Contents


Vitae Pharmaceuticals, Inc.

Notes to the Financial Statements (Continued)

For the Years Ended December 31, 2013 and 2012

5. Fair Value Measurements (Continued)

        The table below sets forth a summary of changes in fair value of the Company's Level 3 financial instruments measured on a recurring basis:

 
  Preferred Stock
Warrant
Liability
 

Balance as of January 1, 2012

  $ 963,375  

Amounts acquired or issued

     

Transfers in and/or out of Level 3

     

Changes in estimated fair value

    (243,000 )
       

Balance as of December 31, 2012

    720,375  

Amounts acquired or issued

     

Transfers in and/or out of Level 3

     

Changes in estimated fair value

    (243,000 )
       

Balance as of December 31, 2013

  $ 477,375  
       
       

6. Investments

Marketable Securities

        Marketable securities consisted of the following as of December 31, 2013 and 2012:

 
  Cost Basis   Unrealized Gains   Unrealized Losses   Fair Value  

December 31, 2013

                         

U.S. government and agency

  $ 500,066   $ 64   $   $ 500,130  

Corporate notes and bonds

    10,799,073     1,964     (1,961 )   10,799,076  
                   

Total marketable securities

  $ 11,299,139   $ 2,028   $ (1,961 ) $ 11,299,206  
                   
                   

December 31, 2012

                         

U.S. government and agency

  $ 1,400,098   $ 897   $   $ 1,400,995  

Corporate notes and bonds

    15,749,861     3,653     (1,577 )   15,751,937  
                   

Total marketable securities

  $ 17,149,959   $ 4,550   $ (1,577 ) $ 17,152,932  
                   
                   

        As of December 31, 2013, the Company's marketable securities had the following maturities:

 
  Cost Basis   Fair Value  

Less than one year

  $ 11,299,139   $ 11,299,206  

One to five years

         
           

  $ 11,299,139   $ 11,299,206  
           
           

F-21